Dld Asset Management, LP Sarepta Therapeutics, Inc. Put Options Transaction History

Dld Asset Management, LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $46,850 - $70,765	-500 Reduced 5.0%	9,500 $1.23 Million
Q4 2023 Feb 12, 2024	BUY	$67.31 - $124.76 $673,100 - $1.25 Million	10,000 New	10,000 $964,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $659,700 - $924,800	-10,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $693,800 - $867,500	-10,000 Reduced 50.0%	10,000 $778,000
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $1.45 Million - $3.38 Million	20,000 New	20,000 $1.49 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $2.41 Million - $4.27 Million	-31,500 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $2.29 Million - $4.94 Million	31,500 New	31,500 $2.37 Million
Q1 2019 May 14, 2019	SELL	$106.67 - $151.68 $4.14 Million - $5.89 Million	-38,800 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $3.78 Million - $5.77 Million	38,800 New	38,800 $4.24 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.